$ABT

The Medical Foods and Formulas Access Act of 2025 expands access to medical foods and formulas, directly benefiting manufacturers and distributors. This legislation increases the market for specialized nutritional products, driving revenue growth for key industry players.

The Access to Pediatric Technologies Act of 2025 (HR1931) will accelerate the development and availability of medical devices and drugs for pediatric use. This creates a new market opportunity for pharmaceutical and medical device companies, driving increased R&D and product launches in the pediatric segment.

The Protect Infant Formula from Contamination Act increases regulatory oversight and reporting requirements for infant formula manufacturers. This bill mandates stricter contamination reporting, directly impacting operational costs and compliance for major producers. The market will see increased compliance spending and potential supply chain adjustments.